Prolyl carboxypeptidase (PCP) catalyzes the formation of ANG-(1-7) from angiotensin II at acidic pH in the kidney, demonstrating an ACE2-independent pathway.
No takes yet. Share an insight, caveat, or question.
Highlights PCP as potential ACE2-independent target in acidic kidney environments; leaves open clinical relevance pending human studies.
Grobe et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: